Related Experiment Video

Updated: Jul 3, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Hepatitis C infection and nonalcoholic fatty liver disease

Onpan Cheung1, Arun J Sanyal

  • 1Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA 23298, USA.

Clinics in Liver Disease
|July 16, 2008
PubMed

Insights

Hepatitis C virus (HCV) infection with fatty liver disease worsens outcomes and reduces treatment effectiveness. Understanding the interaction between nonalcoholic fatty liver disease (NAFLD) and HCV is crucial for managing liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Metabolic Diseases

Background:

  • Nonalcoholic fatty liver disease (NAFLD) and Hepatitis C virus (HCV) are leading causes of chronic liver disease.
  • Obesity, insulin resistance, and metabolic syndrome exacerbate NAFLD and HCV, impacting public health.
  • Significant hepatic steatosis in HCV infection correlates with disease severity and poor treatment response.

Purpose of the Study:

  • To explore the complex interactions between NAFLD and HCV.
  • To understand the interplay of host and viral factors in NAFLD-HCV co-infection.
  • To provide insights into managing patients with co-existing NAFLD and HCV.

Main Methods:

  • Literature review of studies on NAFLD and HCV interactions.
  • Analysis of host and viral factors influencing disease progression.
  • Synthesis of current understanding on metabolic and viral impacts.

Main Results:

  • Hepatic steatosis and nonalcoholic steatohepatitis significantly impact HCV disease severity.
  • Obesity and metabolic syndrome are key drivers in the NAFLD-HCV interaction.
  • Understanding these interactions is vital for effective therapeutic strategies.

Conclusions:

  • The interplay between NAFLD and HCV is critical in chronic liver disease management.
  • Host metabolic factors significantly influence HCV pathogenesis and treatment outcomes.
  • Further research into these interactions can lead to improved patient care and outcomes.

More Related Videos

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution04:14

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on: April 16, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...